Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after the pharmaceutical group confirmed that she has now taken on the role on a permanent basis, having been appointed on an interim basis in December 2022.
Sowemimo-Coker highlights the ongoing work on four drug development programs, including awaiting approval from MHRA for the lead program targeting chemotherapy induced peripheral neuropathy.
Proactive UK Ltd
+44 20 7989 0813
View source version on newsdirect.com: https://newsdirect.com/news/oxford-cannabinoid-technologies-confirms-sowemimo-coker-as-permanent-ceo-133451461